AstraZeneca receives A1 rating upgrade from Moodys, outlook stable By Investing.com
AstraZeneca receives A1 rating upgrade from Moodys, outlook stable…
78,000€
2,63%
Echtzeit-Aktienkurs Astrazeneca PLC (Spons. ADRs)
Bid:
Ask:
Nachrichten zur Astrazeneca PLC (Spons. ADRs) Aktie
AstraZeneca Rises Almost 9% in a Month: How to Play the Stock
AZNs key drugs like Lynparza, Tagrisso, Imfinzi, Ultomiris and Fasenra are likely to drive sales in 2025.…
FTSE 100 dips as heavyweight ex-dividends drag, Lloyds soars
The FTSE 100 dropped again on Thursday as companies accounting for a significant proportion of the index traded ex-dividend and…
4 AI Stocks to Watch in the Quantum Computing Revolution
Following the stock markets record-breaking 2024, during which the S&P 500 index returned a spectacular 23%, theres optimism among investors…
Directorate Change
18 February 2025
Non-Executive Board Changes
AstraZeneca PLC announced today that Karen Knudsen will be proposed for election as a Non-Executive Director…